Milestone Capital Acquires MCIP Industrial Enterprises Corp., Enters Pipe Coating Industry

Milestone Capital, Inc., in partnership with D2 Equity Capital, LLC, has taken a majority stake in a newly established entity designed to acquire the assets of MCIP Industrial Enterprises Corp. This acquisition includes MCIP’s pipe coating facilities in Pearland, Texas,…

Read MoreMilestone Capital Acquires MCIP Industrial Enterprises Corp., Enters Pipe Coating Industry

Crystal Clean Undertakes Major PFAS Remediation Project in the Midwest, One of the World’s Largest

Crystal Clean, Inc., a leading provider of specialized environmental and waste management solutions, announced today the completion of its largest PFAS remediation project to date. Utilizing Crystal Clean’s 4never™ solution, the company successfully treated 1.46 million gallons of PFAS-impacted water…

Read MoreCrystal Clean Undertakes Major PFAS Remediation Project in the Midwest, One of the World’s Largest

Strategic Acquisition: Catalyze Partners Acquires Axcend®, Innovators of Portable HPLC Systems

Catalyze Partners, a leader in acquiring and commercializing advanced technology, announced the acquisition of Axcend, LLC today. The transaction, completed on July 15, 2024, marks a significant step for Catalyze Partners in establishing a robust platform in the analytical instrumentation…

Read MoreStrategic Acquisition: Catalyze Partners Acquires Axcend®, Innovators of Portable HPLC Systems

Yara and ATOME PLC Sign Agreement for Sale of Renewable Calcium Ammonium Nitrate (CAN) Fertilizer

Yara, a global leader in crop nutrition, and ATOME PLC, a prominent developer of international green fertilizer projects, have signed a Heads of Terms agreement for the offtake from ATOME’s renewable Calcium Ammonium Nitrate (CAN) project in Villeta, Paraguay. This…

Read MoreYara and ATOME PLC Sign Agreement for Sale of Renewable Calcium Ammonium Nitrate (CAN) Fertilizer

Vividion Therapeutics Plans Expansion with New Global Research and Development Center

Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company known for its advanced discovery technologies targeting traditionally undruggable diseases with precision therapeutics, has announced plans to enhance its global innovation efforts with a new research and development (R&D) center and corporate headquarters…

Read MoreVividion Therapeutics Plans Expansion with New Global Research and Development Center